Diagnostic Performance of a Lower-dose Contrast-Enhanced 4D Dynamic MR Angiography of the Lower Extremities at 3 T Using Multisegmental Time-Resolved Maximum Intensity Projections.
digital subtraction angiography
peripheral arterial disease
time-resolved MR angiography
time-resolved angiography with interleaved stochastic trajectories
Journal
Journal of magnetic resonance imaging : JMRI
ISSN: 1522-2586
Titre abrégé: J Magn Reson Imaging
Pays: United States
ID NLM: 9105850
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
22
03
2021
received:
28
01
2021
accepted:
23
03
2021
pubmed:
8
4
2021
medline:
14
8
2021
entrez:
7
4
2021
Statut:
ppublish
Résumé
For peripheral artery disease (PAD), MR angiography (MRA) is a well-established diagnostic modality providing morphologic and dynamic information comparable to digital subtraction angiography (DSA). However, relatively large amounts of contrast agents are necessary to achieve this. To evaluate the diagnostic accuracy of time-resolved 4D MR-angiography with interleaved stochastic trajectories (TWIST-MRA) by using maximum intensity projections (MIPs) of dynamic images acquired with reduced doses of contrast agent. Retrospective. Forty adult PAD patients yielding 1088 artery segments. A 3.0 T, time-resolved 4D MR-angiography with TWIST-MRA and MIP of dynamic images. DSA was available in 14 patients (256 artery segments) and used as reference standard. Three-segmental MIP reconstructions of TWIST-images after administration of 3 mL of gadolinium-based contrast agent (Gadoteridol/Prohance®, 0.5 M) per anatomical level (pelvis, thighs, and lower legs) yielded 256 artery segments for correlation between MRA and DSA. Three independent observers rated image quality (scale: 1 [nondiagnostic] to 4 [excellent]) and the degree of venous overlay (scale: 0 [none] to 2 [significant]) for all segments. Diagnostic accuracy for the detection of >50% stenosis and artery occlusion was calculated for all observers. Binary classification test (sensitivity, specificity, positive/negative predictive values, diagnostic accuracy). Intraclass correlation coefficients (ICCs), logistic regression analysis with comparison of areas under the receiver-operating-characteristics (ROC) curves (AUCs) with the DeLong method. Bland-Altman-comparison. High diagnostic performance was achieved for the detection of >50% stenosis (sensitivity 92.9% [84.3-99.9% (95%-CI)] and specificity 98.5% [95.7-99.8% (95%-CI)]) and artery occlusion (sensitivity 93.1% [77.2-99.2% (95%-CI)] and specificity 99.1% [96.9-99.9% (95%-CI)]). Inter-reader agreement was excellent with ICC values ranging from 0.95 to 1.0 for >50% artery stenosis and occlusion. Image quality was good to excellent for both readers (3.41 ± 0.72, 3.33 ± 0.65, and 3.38 ± 0.61 [mean ± SD]) with good correlation between observer ratings (ICC 0.71-0.81). No significant venous overlay was observed (0.06 ± 0.24, 0.23 ± 0.43 and 0.11 ± 0.45 [mean ± SD]). MIPs of dynamic TWIST-MRA offer a promising diagnostic alternative necessitating only reduced amounts (50%) of gadolinium-based contrast agents for the entire runoff vasculature. 3 TECHNICAL EFFICACY: Stage 2.
Sections du résumé
BACKGROUND
For peripheral artery disease (PAD), MR angiography (MRA) is a well-established diagnostic modality providing morphologic and dynamic information comparable to digital subtraction angiography (DSA). However, relatively large amounts of contrast agents are necessary to achieve this.
PURPOSE
To evaluate the diagnostic accuracy of time-resolved 4D MR-angiography with interleaved stochastic trajectories (TWIST-MRA) by using maximum intensity projections (MIPs) of dynamic images acquired with reduced doses of contrast agent.
STUDY TYPE
Retrospective.
POPULATION
Forty adult PAD patients yielding 1088 artery segments.
FIELD STRENGTH/SEQUENCE
A 3.0 T, time-resolved 4D MR-angiography with TWIST-MRA and MIP of dynamic images.
ASSESSMENT
DSA was available in 14 patients (256 artery segments) and used as reference standard. Three-segmental MIP reconstructions of TWIST-images after administration of 3 mL of gadolinium-based contrast agent (Gadoteridol/Prohance®, 0.5 M) per anatomical level (pelvis, thighs, and lower legs) yielded 256 artery segments for correlation between MRA and DSA. Three independent observers rated image quality (scale: 1 [nondiagnostic] to 4 [excellent]) and the degree of venous overlay (scale: 0 [none] to 2 [significant]) for all segments. Diagnostic accuracy for the detection of >50% stenosis and artery occlusion was calculated for all observers.
STATISTICAL TESTS
Binary classification test (sensitivity, specificity, positive/negative predictive values, diagnostic accuracy). Intraclass correlation coefficients (ICCs), logistic regression analysis with comparison of areas under the receiver-operating-characteristics (ROC) curves (AUCs) with the DeLong method. Bland-Altman-comparison.
RESULTS
High diagnostic performance was achieved for the detection of >50% stenosis (sensitivity 92.9% [84.3-99.9% (95%-CI)] and specificity 98.5% [95.7-99.8% (95%-CI)]) and artery occlusion (sensitivity 93.1% [77.2-99.2% (95%-CI)] and specificity 99.1% [96.9-99.9% (95%-CI)]). Inter-reader agreement was excellent with ICC values ranging from 0.95 to 1.0 for >50% artery stenosis and occlusion. Image quality was good to excellent for both readers (3.41 ± 0.72, 3.33 ± 0.65, and 3.38 ± 0.61 [mean ± SD]) with good correlation between observer ratings (ICC 0.71-0.81). No significant venous overlay was observed (0.06 ± 0.24, 0.23 ± 0.43 and 0.11 ± 0.45 [mean ± SD]).
DATA CONCLUSION
MIPs of dynamic TWIST-MRA offer a promising diagnostic alternative necessitating only reduced amounts (50%) of gadolinium-based contrast agents for the entire runoff vasculature.
EVIDENCE LEVEL
3 TECHNICAL EFFICACY: Stage 2.
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
763-774Informations de copyright
© 2021 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC. on behalf of International Society for Magnetic Resonance in Medicine.
Références
Escobar C, Blanes I, Ruiz A, et al. Prevalence and clinical profile and management of peripheral arterial disease in elderly patients with diabetes. Eur J Intern Med 2011;22(3):275-281.
Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996;25(6):1172-1181.
Ghibes P, Hefferman G, Nikolaou K, et al. Quantitative evaluation of peripheral arterial blood flow using Peri-interventional fluoroscopic parameters: An in vivo study evaluating feasibility and clinical utility. Biomed Res Int 2020;2020(9526790):1-8.
Hay JW, Lawler E, Yucel K, et al. Cost impact of diagnostic imaging for lower extremity peripheral vascular occlusive disease. Value Health 2009;12(2):262-266.
Bui BT, Miller S, Mildenberger P, Sam A, Sheng R. Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: Results of a phase III multicenter trial. J Magn Reson Imaging 2010;31(6):1402-1410.
Vogt FM, Zenge MO, Ladd ME, et al. Peripheral vascular disease: Comparison of continuous MR angiography and conventional MR angiography-pilot study. Radiology 2007;243(1):229-238.
Schernthaner R, Stadler A, Lomoschitz F, et al. Multidetector CT angiography in the assessment of peripheral arterial occlusive disease: Accuracy in detecting the severity, number, and length of stenoses. Eur Radiol 2008;18(4):665-671.
Hodnett PA, Ward EV, Davarpanah AH, et al. Peripheral arterial disease in a symptomatic diabetic population: Prospective comparison of rapid unenhanced MR angiography (MRA) with contrast-enhanced MRA. AJR Am J Roentgenol 2011;197(6):1466-1473.
Klasen J, Blondin D, Schmitt P, et al. Nonenhanced ECG-gated quiescent-interval single-shot MRA (QISS-MRA) of the lower extremities: Comparison with contrast-enhanced MRA. Clin Radiol 2012;67(5):441-446.
Hansmann J, Morelli JN, Michaely HJ, et al. Nonenhanced ECG-gated quiescent-interval single shot MRA: Image quality and stenosis assessment at 3 tesla compared with contrast-enhanced MRA and digital subtraction angiography. J Magn Reson Imaging 2014;39(6):1486-1493.
Versluis B, Nelemans PJ, Wildberger JE, Schurink GW, Leiner T, Backes WH. Magnetic resonance imaging-derived arterial peak flow in peripheral arterial disease: Towards a standardized measurement. Eur J Vasc Endovasc Surg 2014;48(2):185-192.
Meissner OA, Rieger J, Weber C, et al. Critical limb ischemia: Hybrid MR angiography compared with DSA. Radiology 2005;235(1):308-318.
Berg F, Bangard C, Bovenschulte H, et al. Hybrid contrast-enhanced MR angiography of pelvic and lower extremity vasculature at 3.0 T: Initial experience. Eur J Radiol 2009;70(1):170-176.
Wang CC, Liang HL, Hsiao CC, et al. Single-dose time-resolved contrast enhanced hybrid MR angiography in diagnosis of peripheral arterial disease: Compared with digital subtraction angiography. J Magn Reson Imaging 2010;32(4):935-942.
Attenberger UI, Haneder S, Morelli JN, Diehl SJ, Schoenberg SO, Michaely HJ. Peripheral arterial occlusive disease: Evaluation of a high spatial and temporal resolution 3-T MR protocol with a low total dose of gadolinium versus conventional angiography. Radiology 2010;257(3):879-887.
Kinner S, Quick HH, Maderwald S, Hunold P, Barkhausen J, Vogt FM. Triple-TWIST MRA: High spatial and temporal resolution MR angiography of the entire peripheral vascular system using a time-resolved 4D MRA technique. Eur Radiol 2013;23(1):298-306.
Murata N, Gonzalez-Cuyar LF, Murata K, et al. Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: Preliminary results from 9 patients with normal renal function. Invest Radiol 2016;51(7):447-453.
Murata N, Murata K, Gonzalez-Cuyar LF, Maravilla KR. Gadolinium tissue deposition in brain and bone. Magn Reson Imaging 2016;34(10):1359-1365.
Bannas P, Finck-Wedel AK, Buhk JH, et al. Comparison of whole body MR angiography at 1.5 and 3 Tesla in patients with hereditary hyperlipidemia. Acta Radiol 2011;52(5):547-553.
Shen Y, Goerner FL, Snyder C, et al. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T. Invest Radiol 2015;50(5):330-338.
Attenberger UI, Michaely HJ, Wintersperger BJ, et al. Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: Interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T. Eur Radiol 2008;18(6):1260-1268.
Schieda N, Blaichman JI, Costa AF, et al. Gadolinium-based contrast agents in kidney disease: A comprehensive review and clinical practice guideline issued by the Canadian Association of Radiologists. Can J Kidney Health Dis 2018;5:2054358118778573.
Song T, Laine AF, Chen Q, et al. Optimal k-space sampling for dynamic contrast-enhanced MRI with an application to MR renography. Magn Reson Med 2009;61(5):1242-1248.
Lim RP, Shapiro M, Wang EY, et al. 3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: Comparison with 3D contrast-enhanced bolus-chase MRA and 3D time-of-flight MRA. AJNR Am J Neuroradiol 2008;29(10):1847-1854.
Roberson PK, Shema SJ, Mundfrom DJ, Holmes TM. Analysis of paired Likert data: How to evaluate change and preference questions. Fam Med 1995;27(10):671-675.
Stratton SJ. Likert Data. Prehosp Disaster Med 2018;33(2):117-118.
Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group. JAMA 1995;274(11):875-880.
Woolen SA, Shankar PR, Gagnier JJ, MacEachern MP, Singer L, Davenport MS. Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: A systematic review and meta-analysis. JAMA Intern Med 2020;180(2):223-230.
Semelka RC, Ramalho J, Vakharia A, et al. Gadolinium deposition disease: Initial description of a disease that has been around for a while. Magn Reson Imaging 2016;34(10):1383-1390.
Semelka RC, Ramalho M, AlObaidy M, Ramalho J. Gadolinium in humans: A family of disorders. AJR Am J Roentgenol 2016;207(2):229-233.
McDonald RJ, McDonald JS, Kallmes DF, et al. Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial abnormalities. Radiology 2017;285(2):546-554.
Sanyal S, Marckmann P, Scherer S, Abraham JL. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis-an autopsy-based review. Nephrol Dial Transplant 2011;26(11):3616-3626.
Attenberger UI, Liu J, Riffel P, et al. Quantitative perfusion analysis of the rectum using Golden-angle radial sparse parallel magnetic resonance imaging: Initial experience and comparison to time-resolved angiography with interleaved stochastic trajectories. Invest Radiol 2017;52(12):715-724.
Feng L, Grimm R, Block KT, et al. Golden-angle radial sparse parallel MRI: Combination of compressed sensing, parallel imaging, and golden-angle radial sampling for fast and flexible dynamic volumetric MRI. Magn Reson Med 2014;72(3):707-717.
Highlights of Prescribing Information; Gadovist (Gadobutrol, Bayer Health Care Pharmaceuticals, 1.0 M). Accessed on March 15, 2021. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201277s000lbl.pdf
Thomsen HS, Morcos SK, Almen T, et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: Updated ESUR contrast medium safety committee guidelines. Eur Radiol 2013;23(2):307-318.
Ganguli S, Pedrosa I, Smith MP, Niendorf ER, Fredericks S, Rofsky NM. Low dose pedal magnetic resonance angiography at 3 tesla with time-resolved imaging of contrast kinetics: A feasibility study. Invest Radiol 2008;43(9):650-655.
Miyazaki M, Lee VS. Nonenhanced MR angiography. Radiology 2008;248(1):20-43.
Wagner M, Knobloch G, Gielen M, et al. Nonenhanced peripheral MR-angiography (MRA) at 3 tesla: Evaluation of quiescent-interval single-shot MRA in patients undergoing digital subtraction angiography. Int J Cardiovasc Imaging 2015;31(4):841-850.
Knobloch G, Gielen M, Lauff MT, et al. ECG-gated quiescent-interval single-shot MR angiography of the lower extremities: Initial experience at 3 T. Clin Radiol 2014;69(5):485-491.